Why Elon Musk And Sam Altman Think Christopher Nolan's 'Oppenheimer' Missed The Mark

Comments
Loading...

Tech titans Elon Musk and Sam Altman have made an unlikely alliance to voice disappointment over the controversial biopic “Oppenheimer.” 

What Happened: During the weekend, OpenAI CEO Altman took to social media and said he hoped that “Oppenheimer” would inspire a new generation of aspiring physicists. However, the film failed to achieve this objective and “missed the mark.” 

See Also: Elon Musk Preaches AI Regulations Left And Right, But Got Snubbed By Biden Administration Again

The CEO of ChatGPT-parent also gave reference to the movie “The Social Network,” a 2010 film that narrated the story of Mark Zuckerberg and the creation of Facebook, saying the movie successfully inspired aspiring startup founders. 

In a brief response to the tweet, Musk echoed Altman’s sentiments with a simple “Indeed.”

Oppenheimer is directed and written by acclaimed filmmaker Christopher Nolan. The movie delves into the life of J. Robert Oppenheimer, the prominent physicist responsible for his involvement in developing the first nuclear weapons during the Manhattan Project. 

Starring Cillian Murphy as Oppenheimer, the film aims to depict the life and struggles of the physicist. 

Why It’s Important: Musk, who co-founded ChatGPT-parent in 2015 alongside Altman and others and left the company in 2018, doesn’t see eye to eye with OpenAI’s CEO on many things.

However, they both previously expressed similar concerns about the dangers of AI.

Musk reportedly wanted to run OpenAI by himself, but fellow co-founders turned down his proposal.

Check out more of Benzinga’s Consumer Tech coverage by following this link.

Read Next: Sundar Pichai Agrees With Sam Altman, Elon Musk: AI Is Too ‘Important Not To Regulate Well’

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!